• PRODUCT AVAILABILITY: Did you know you can view a product's availability right on the product page? Simply enter the quantity you want to purchase and the current availability will appear below the item.

Hardy Diagnostics


Not yet rated

A cost-effective, targeted approach to identifying methicillin-resistant Staphylococcus aureus (MRSA). A rapid lateral flow assay procedure that's simpler than latex agglutination, faster than culturing, and takes the subjectivity out of reading the result. Results in 5 minutes, sample from culture (wound, skin, urine, etc.), easy to handle test strip, built-in quality controls on every test strip.

  • See below to view the Instructions For Use (IFU), MSDS, and color brochures that feature the many other rapid test methods offered by Hardy.
  • The Hardy Diagnostics manufacturing facility and quality management system comply with the FDA's Good Manufacturing Practices (GMP) and have achieved ISO 13485 certification as a medical device manufacturer.
  • Quality is a science...Service is an art. At Hardy Diagnostics, we believe in excellence in patient care...just like you do.
  • Please Enter Your Order Info

    Filter by:

    • Clear Filters
    Product Detail
    Thomas No.
    Mfr. No.
    CLEARVIEW™ PBP2a, a rapid lateral flow assay procedure for identifying methicillin-resistant Staphylococcus aureus (MRSA), 25 tests, no UN required
    list price/quantitytotal
    $0.00 (0 Items)

    Write A Review